{"id":1172,"date":"2019-06-16T17:48:24","date_gmt":"2019-06-16T09:48:24","guid":{"rendered":"http:\/\/www.bioactivescreeninglibrary.com\/?p=1172"},"modified":"2022-01-07T10:53:32","modified_gmt":"2022-01-07T02:53:32","slug":"gain-mutations-gphrs-popular-approach-current-wake-promoting-agents","status":"publish","type":"post","link":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/06\/16\/gain-mutations-gphrs-popular-approach-current-wake-promoting-agents\/","title":{"rendered":"Though gain mutations in GpHRs has been a popular approach to by current wake-promoting agents"},"content":{"rendered":"

Seems a valid target for the development of future sleep countermeasures. No currently available sleep countermeasures allow human ‘normal wake’ performance over extended periods of time. Frank limitations include dissociative\/psychotic behavior after prolonged exposure, risk of developing tolerance\/dependence on the agents being used, and lowered seizure thresholds. Our microarray results indicate that synaptic function-related mRNA expression changes do not occur in a vacuum. Among other categories of change, the reduction in intercellular adhesion molecule expression may be of particular importance. These molecules are pleiotropic and in addition to playing a role in inflammation and immune signaling, also help maintain synaptic juxtaposition. We speculate that their downregulation in SD could leading to aberrant synaptic signaling. Thus, the development of drugs targeting the stabilization of intercellular adhesion molecules may help to extend the duration of action for stimulant-based sleep countering agents.1. Our findings support long-standing observations that SD elicits physiologic and transcriptional responses with stress-like features. Neuronal synaptic gene expression changes may help to explain the benefits and limitations of current stimulant-based SD-countering therapeutics and points to novel targets in presynaptic vesicular release and neural cell adhesion for development of future SD-countering drugs. Significantly more genes than expected by chance were commonly regulated by both aging and SD. Although many were driven in the same direction by these two phenomena, we could not fully support the hypothesis that SD evokes an aging-like transcriptional change. Genes showing significant but opposite expression changes in SD and aging, including Chrbp, Fkbp4, Homer1 and Per2, are candidates for further study of the interplay between SD and aging. Compared to prior studies showing increased inflammatory signaling with stress, our novel environment stress protocol did not influence inflammatory gene expression to an appreciable extent, and SD suppressed those signals. This suggests that SD in our hands was either a weak stressor, or that it has an effect mechanistically distinct from that of stress on immune signaling. One of the receptor activation models suggests that the C-terminal region of ECD, which links LRRs to TMD, acts as a flexible “hinge”, enabling the hormone bound LRR to communicate with the Extracellular loops of TMD. The scaffold model, however, does not explain the cryptic hormone binding sites in the hinge region of FSHR or the interaction of the a-subunit of hormones with the hinge regions. Removal of ECD by trypsin treatment, or mutations or deletions in the hinge region cause an increase in hormone-independent activation by releasing the silencing effect of the ECD and have since given rise to the tethered inverse agonist model in which ECD Gomisin-D<\/a> serves as an inverse agonist stabilizing TMD in an inactive conformation. Hormone binding or activating mutations in the hinge region disengages these inhibitory ECD-TMD Lomitapide Mesylate<\/a> interactions. However, this model is inadequate to explain relatively low activation of hinge region constitutively activating mutations like K287A or K291A compared to that caused by the hormone even with ample expression of these mutants on cell surface. It also does not explain lack of hormone-independent activation of LHR or why S277Q in LHR responds to hCG but TSHR homologous mutation S281Q does not respond to TSH, although certain mutations in the critical S281 residue has the potential of stimulating TSHR comparable to the hormone.<\/p>\n","protected":false},"excerpt":{"rendered":"

Seems a valid target for the development of future sleep countermeasures. No currently available sleep countermeasures allow human ‘normal wake’ performance over extended periods of time. Frank limitations include dissociative\/psychotic behavior after prolonged exposure, risk of developing tolerance\/dependence on the agents being used, and lowered seizure thresholds. Our microarray results indicate that synaptic function-related mRNA … Continue reading “Though gain mutations in GpHRs has been a popular approach to by current wake-promoting agents”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1172"}],"collection":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=1172"}],"version-history":[{"count":1,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1172\/revisions"}],"predecessor-version":[{"id":1173,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1172\/revisions\/1173"}],"wp:attachment":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=1172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=1172"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=1172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}